Description
This product utilizes regulatory B cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone R6U7J4). We employs the Adenovirus (CMV-Cy5-IL-4-SpeI) vector components and the SynExpress system of the introns Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD22
Clone
R6U7J4
Species Reactivity
Human
Cell Source
Regulatory B cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
SpeI
Gene Modification
Knock-in
Modification Domain
Introns
Carrier Type
Adenovirus
Transformation Accuracy
0.95
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.